Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0600
+0.0100 (20.00%)
Oct 9, 2026, 3:58 PM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 20.37 million as of October 9, 2026. It is the 39,504th most valuable company in the world and the 1,324th biggest in Canada. Its market cap has increased by 53.39% in one year.
Market Cap
20.37M
Enterprise Value
16.82M
Revenue
n/a
Global Rank
Country Rank
#1,324 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has increased from 17.41M to 20.37M, an increase of 17.00%. That is a compound annual growth rate of 2.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 20.37M | 68.00% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sona Nanotech | 36.84M |
| Telescope Innovations | 33.54M |
| Defence Therapeutics | 30.32M |
| Resverlogix | 29.26M |
| The More Life Company | 27.42M |
| Pharmala Biotech Holdings | 23.58M |
| Devonian Health Group | 22.94M |
| Onco-Innovations | 22.15M |